Agena Bioscience® in the News

Recent Press Releases

  • Agena Bioscience Announces Collaboration with PerkinElmer More

    Combining LabChip® GX Touch Nucleic Acid Analyzer and MassARRAY® for Optimized Liquid Biopsy WorkflowSan...

  • Agena Announces MassARRAY® Technology Selected for Participation in CANCER-ID Consortium More

    San Diego, CA, July 24, 2018 – Agena Bioscience, a global provider of molecular testing solutions, announced today that...

  • Agena Announces MassARRAY® Commercial Partnership Agreement With Dian For China Clinical Laboratory Market More

    San Diego, CA, July 10, 2018 – Agena Bioscience announced today that it has entered into a commercial partnership agreement...

  • GenomeWeb 360Dx: Agena Looks to China for Global Expansion of the MassARRAY Platform More

    New York, NY (360DX), June 6, 2018 –  For Agena Bioscience CEO Peter Dansky, expanding a diagnostics company means going...

  • Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China More

    San Diego, CA, and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the...

  • Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union More

    San Diego, CA, November 30, 2017 – Agena Bioscience, a global provider of molecular genetic solutions, today announced...

  • Agena Bioscience Bolsters MassARRAY Insights™ Reporting Network by Adding N-of-One More

    The collaboration will focus on results interpretation for cancer genomics.San Diego, CA, October 5, 2017– Agena Bioscience,...

  • Highly Sensitive Assessment Of Common Somatic Mutations In Pulmonary Non-Small Cell Carcinoma With the MassARRAY® System More

    San Diego, CA, September 27, 2017 – Agena Bioscience today announced a comparative study published in PLOS ONE highlighting...

  • Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights™ More

    MassARRAY Insights providers will aid in results interpretationSan Diego, CA, September 19, 2017– Agena Bioscience, a...

  • Intermountain Precision Genomics Launches Antidepressant PGx Panels Developed on Agena MassARRAY® More

    NEW YORK, Sept 15, 2017 – Intermountain Precision Genomics’ RxMatch Antidepressant Panel, announced last week, is the...

  • MassARRAY® System Selected for Illinois State Cystic Fibrosis Screening of Newborns More

    San Diego, CA, August 2, 2017– Agena Bioscience has entered into a 3-year agreement with the Illinois Department of Public...

  • Agena Bioscience and Heartgenetics Announce Co-Marketing Alliance More

    HEARTDECODE® Software and Assays Designed for Use with the MassARRAY® DX SystemSan Diego, CA,...